Evaluation of Financial Performance of Asset-Light Operation Mode: A Case Study

Abstract

The pharmaceutical industry is a core industry related to the national economy and people's livelihood, and has a very large development potential.The rapid development of China's national economy and the increasing improvement of people's living standards, in the face of the ever-changing external environment, how to grasp the opportunity to seize the trend of the times to meet greater challenges, is a problem that all pharmaceutical companies need to think about.Asset-light operation mode emphasizes research and development as the guide, attaches importance to product innovation, brand building, market development, marketing system construction, fully integrates internal and external resources, improves the efficiency of the use of resources, so that the enterprise is always in a favorable position in the market competition.Hengrui Medicine has been developing rapidly in recent years, with good financial data, which relies on the asset-light operation mode.Therefore, this paper chooses Hengrui Medicine as the case study object, expounds the concept and relevant theories of asset-light operation mode, summarizes the financial characteristics and performance of the enterprise adopting the asset-light operation mode, and finally compares and analyzes the impact of the asset-light operation mode on the financial performance of the enterprise, so as to bring some experiential enlightenment for the transformation of the pharmaceutical industry's asset-light mode.